Fernando Fuertes
Publications by Year
Research Areas
Genetic Associations and Epidemiology, Prostate Cancer Treatment and Research, Prostate Cancer Diagnosis and Treatment, Nitric Oxide and Endothelin Effects, Coronary Interventions and Diagnostics
Most-Cited Works
- → Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes(2007)724 cited
- → Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer(2008)372 cited
- → Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility(2009)351 cited
- → A germline variant in the TP53 polyadenylation signal confers cancer susceptibility(2011)303 cited
- → A study based on whole-genome sequencing yields a rare variant at 8q24 associated with prostate cancer(2012)189 cited
- → Genetic Correction of PSA Values Using Sequence Variants Associated with PSA Levels(2010)165 cited
- → Lymphangiosarcoma in a Chronic Lymphedematous Limb: A Case Report(1995)7 cited
- → 4CPS-147 Clinical experience of optimising co-administration therapy of low-dose allopurinol with low-dose thiopurines in inflammatory bowel disease patients attending a virtual pharmacist clinic(2019)1 cited
- → Four common genetic variants increase susceptibility to prostate cancer in the Spanish population(2008)
- → PD-0534: Dose-escalation phase III trial of preoperative chemoradiotherapy in rectal cancer. First results(2020)